- Previous Close
201.60 - Open
199.30 - Bid 180.15 x --
- Ask 193.10 x --
- Day's Range
185.10 - 204.50 - 52 Week Range
184.85 - 400.00 - Volume
86,043 - Avg. Volume
14,080 - Market Cap (intraday)
15.592B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
25.95 - EPS (TTM)
7.22 - Earnings Date Apr 16, 2025
- Forward Dividend & Yield 1.44 (0.60%)
- Ex-Dividend Date Mar 30, 2023
- 1y Target Est
--
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. It offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, as well as software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and membrane filters, glass and quartz microfibre filters, syringeless and in-line filters, lab chromatography, and filters and blotting papers. The company also provides live-cell analysis systems, reagents and consumables, and live-cell imaging and analysis software; equipment manufacturer membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and detection systems, sensor chips and consumables, systems, biosensors and kits, compliance tools, and systems software. Further, it offers water purification systems; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, it provides bioprocess consulting and engineering, media and process, instrument, system service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
www.sartorius.com15,942
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 0NIR.IL
View MorePerformance Overview: 0NIR.IL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0NIR.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0NIR.IL
View MoreValuation Measures
Market Cap
11.73B
Enterprise Value
15.46B
Trailing P/E
154.86
Forward P/E
38.17
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.90
Price/Book (mrq)
4.68
Enterprise Value/Revenue
4.57
Enterprise Value/EBITDA
19.65
Financial Highlights
Profitability and Income Statement
Profit Margin
9.76%
Return on Assets (ttm)
5.37%
Return on Equity (ttm)
18.21%
Revenue (ttm)
3.61B
Net Income Avi to Common (ttm)
352M
Diluted EPS (ttm)
7.22
Balance Sheet and Cash Flow
Total Cash (mrq)
293.9M
Total Debt/Equity (mrq)
195.45%
Levered Free Cash Flow (ttm)
-35.81M